Sartori F, Rea F, Calabrò F, Mazzucco C, Bortolotti L, Tomio L
First Department of Surgery, University of Padua, Italy.
J Thorac Cardiovasc Surg. 1992 Sep;104(3):679-83.
Fifty-six patients with superior sulcus syndrome were evaluated at the First Surgical Department of the University of Padua between 1981 and 1990. Forty-two patients with the characteristic of Pancoast's tumor received preoperative irradiation and then en bloc resection of the tumor, chest wall, and adjacent structures. Seven lobectomies and 35 segmentectomies or wedge resections were performed. There was one early postoperative death. Median survival was 14 months, and actuarial survival was 25% at 5 years. Patients with pain relief had better 5-year survival (36.4%) than patients without pain relief (9%). We have no patients with vertebral invasion who survived more than 1 year. Of the five patients with subclavian artery invasion, only one survived more than 1 year. Of five patients with N2 disease, only one survived more than 1 year. Our results suggest that pain relief after irradiation is a good prognostic factor, whereas N2 involvement and vertebral body and great vessel invasion are ominous factors. Another ominous prognostic factor is the Claude Bernard-Horner syndrome even if it is not a contraindication to resection.
1981年至1990年间,帕多瓦大学第一外科对56例肺上沟瘤综合征患者进行了评估。42例具有潘科斯特瘤特征的患者接受了术前放疗,然后整块切除肿瘤、胸壁及相邻结构。实施了7例肺叶切除术以及35例肺段切除术或楔形切除术。术后早期死亡1例。中位生存期为14个月,5年精算生存率为25%。疼痛缓解的患者5年生存率(36.4%)高于未缓解的患者(9%)。我们没有椎体侵犯且存活超过1年的患者。5例锁骨下动脉侵犯患者中,仅1例存活超过1年。5例N2期疾病患者中,仅1例存活超过1年。我们的结果表明,放疗后疼痛缓解是一个良好的预后因素,而N2受累、椎体及大血管侵犯则是不良因素。另一个不良预后因素是克劳德·伯纳德 - 霍纳综合征,即便它并非手术禁忌证。